• Home
• Responsibility
• Research practices
• Emerging technologies
• Collaborative research on emerging technologies

Corporate Responsibility Report 2008

Collaborative research on emerging technologies

New scientific knowledge and technologies can be developed for application to medicine discovery and development through collaborative research that combines resources, expertise and know-how from several partners. The benefit of this research is often realised by making the results widely available to the research community.

For example, we are an active participant in the Innovative Medicines Initiative (IMI) a public-private partnership set up by the European Commission and the pharmaceutical industry through the European Federation of Pharmaceutical Industries and Associations (EFPIA). The IMI will support and stimulate collaborative research in Europe involving pharmaceutical companies, smaller bioscience companies, academia, regulators and patient groups with the aim of removing barriers to the discovery and development of new medicines.

Read more about our investment in R&D and new technologies.

More on our partnerships and academic collaborations.